Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001103021-19-000061)

Filing Details

Accession Number:: 0001103021-19-000061
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-12-31 16:20:54
Reporting Period:: 2019-12-26

Accepted Time:: 2019-12-31 16:20:54
Original Submission Date:: 2019-12-31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1103021	Biodelivery Sciences International Inc	BDSI	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1066040	Jr E Francis Odonnell	C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-26	10,000	$1.96	574,754	No	4	M	Direct
Common Stock	Disposition	2019-12-26	10,000	$7.00	564,754	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Disposition	2019-12-26	10,000	$0.00	10,000	$1.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-02-12	2022-02-12	No	4	M	Direct

Footnotes

This Form 4/A amends the Reporting Person's Form 4 filed on December 30, 2019 to reflect that the shares of Common Stock were sold following the automatic exercise of the Reporting Person's stock options (right to buy).